Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Neratinib HER Mutation Basket Study
Multiple Cancer Types
This is an open-label, multicenter, multinational, Phase 2 basket study exploring the efficacy and safety of neratinib as monotherapy or in combination with other therapies in participants with HER (EGFR, HER2) mutation-positive solid tumors.
Bladder,
Colon,
Esophageal,
Gastric/Gastroesophageal,
Neuro-Oncology,
Ovarian,
Urologic,
Uterine
II
Mayer, Ingrid
NCT01953926
VICCMD1403
A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors
Multiple Cancer Types
This is a Phase 1, open label, multi center, dose escalation and expansion, safety, tolerability, PK, and pharmacodynamics study of PF 06939999 in previously treated patients with advanced or metastatic cancer.
Bladder,
Cervical,
Esophageal,
Head/Neck,
Lung,
Non Small Cell,
Phase I,
Uterine
I
Berlin, Jordan
NCT03854227
VICCPHI1909